Moneycontrol PRO
HomeAuthorVaibhavi ranjan News

Vaibhavi Ranjan

Correspondent

Moneycontrol

Apollo Hospitals shares gain as Jefferies raises target price; sees 26% upside

BUSINESS

Apollo Hospitals shares gain as Jefferies raises target price; sees 26% upside

Motilal Oswal Financial Services and Prabhudas Lilladher also have a Buy rating for the healthcare major

Apollo Hospitals’ digital business revenue set to improve: MD Suneeta Reddy

BUSINESS

Apollo Hospitals’ digital business revenue set to improve: MD Suneeta Reddy

The diagnostics and retail health and the digital health and pharmacy distribution verticals reported a combined loss of Rs 107.3 crore in the third quarter, mainly due to discounts offered to onboard customers.

Uflex plummets 7% after reporting net loss of Rs 85 crore in December quarter

BUSINESS

Uflex plummets 7% after reporting net loss of Rs 85 crore in December quarter

The company reported a net loss of Rs 85 crore against a profit of Rs 313 crore in the same period a year ago

TCNS Clothing Co shares slump to 52-week low on disappointing Q3 results

BUSINESS

TCNS Clothing Co shares slump to 52-week low on disappointing Q3 results

Emkay Global Financial Services and Asian Markets Securities maintain a hold rating for the stock.

Apollo Hospitals Q3 result: Net profit declines 33.3%; misses Street's estimate

BUSINESS

Apollo Hospitals Q3 result: Net profit declines 33.3%; misses Street's estimate

Revenue growth was driven by higher pharmacy sales, better revenue mix, and normalisation of medical tourism

Bharat Forge shares shed nearly 3% after sharp drop in Q3 net profit

BUSINESS

Bharat Forge shares shed nearly 3% after sharp drop in Q3 net profit

The decline in net profit was due to an overseas operational loss due to ramp up related issues of the new Al forgings capacities in Germany and the US

Glenmark Pharma surges as Nomura raises target price, sees 50% upside

BUSINESS

Glenmark Pharma surges as Nomura raises target price, sees 50% upside

Nomura has a 'buy' rating for Glenmark Pharma with a target price of Rs 633

Apollo Hospitals trades lower as investors turn cautious ahead of Q3 results

BUSINESS

Apollo Hospitals trades lower as investors turn cautious ahead of Q3 results

Revenues are expected to rise in the December quarter, but EBIDTA margin is likely to be under pressure

Pessimism grows for Lupin on delayed product launches, high valuations; here's what brokerages say

BUSINESS

Pessimism grows for Lupin on delayed product launches, high valuations; here's what brokerages say

This follows a 72% fall in net profit for the October-December quarter, albeit on a higher base.

Info Edge shares nosedive 10% on report of net loss in Oct-Dec

BUSINESS

Info Edge shares nosedive 10% on report of net loss in Oct-Dec

JM Financial, HDFC Securities and YES Securities gave a Buy call for Info Edge (India).

Which sectors will spearhead returns in the coming decade? Here's what the experts are betting on

BUSINESS

Which sectors will spearhead returns in the coming decade? Here's what the experts are betting on

Alas, new-age tech firms are not among them, as they still need to show earnings growth visibility before they can be deemed worthy of investment.

This is how you generate outsized returns, say market experts

BUSINESS

This is how you generate outsized returns, say market experts

Don’t just gun for the big game. Explore the back-alleys of the stock market and find the small firms that may become the darlings of the street over the next decade

Sundaram Alternate's Vikaas M Sachdeva is bullish on India; here are his top sectoral themes

BUSINESS

Sundaram Alternate's Vikaas M Sachdeva is bullish on India; here are his top sectoral themes

Vikaas M Sachdeva expects India's GDP to more than double in the coming decade, and believes the economy is set to fire on two fronts-consumption and investment.

Devyani International trades lower on weak operational performance in Q3

BUSINESS

Devyani International trades lower on weak operational performance in Q3

Brokerage firms Motilal Oswal Financial Services and Jefferies have cut their price targets for Devyani International but have retained 'buy' call on the stock

Akzo Nobel shines on best-ever quarter, shares up over 6%

BUSINESS

Akzo Nobel shines on best-ever quarter, shares up over 6%

The paint-maker's consolidated net profit rose 16.2 percent year-on-year to Rs 97.4 crore in the December quarter

Decline in Q3 net profit drags Lupin; stock slumps 6%

BUSINESS

Decline in Q3 net profit drags Lupin; stock slumps 6%

The drugmaker's bottomline for the Oct-Dec period fell 72 percent on year primarily due to a high base in the corresponding quarter last year.

Lupin shares trade flat ahead of Q3 result; here's what to expect

BUSINESS

Lupin shares trade flat ahead of Q3 result; here's what to expect

The EBIDTA margin is likely to improve sequentially on the back of a marginal recovery in US sales and sustained cost-cutting measures

MC Explains | The case of MSCI's review of Adani Group stocks

BUSINESS

MC Explains | The case of MSCI's review of Adani Group stocks

If the free float of Adani Group stocks is lowered, a few names will risk getting deleted from the index while the weightage of others can be reduced.

Analyst Call Tracker: How Infosys bucked the pessimistic outlook for IT cos

BUSINESS

Analyst Call Tracker: How Infosys bucked the pessimistic outlook for IT cos

Infosys had revised its revenue guidance for FY23 to 16-16.5% from 15-16% earlier.

Analyst Call Tracker: Why are fireworks missing for JSW Steel even as China reopens

BUSINESS

Analyst Call Tracker: Why are fireworks missing for JSW Steel even as China reopens

Out of the 32 brokerages covering JSW Steel, 26 of them had a "sell" or "hold" rating, with high valuations of the stock remaining a concern

Vinati Organics shares ride high for 3rd day on upbeat Oct-Dec operational show

BUSINESS

Vinati Organics shares ride high for 3rd day on upbeat Oct-Dec operational show

Motilal Oswal Financial Services and Centrum Broking have a Buy call for the stock

Zomato shares surge ahead of Oct-Dec earnings, CLSA sees 42% upside potential

BUSINESS

Zomato shares surge ahead of Oct-Dec earnings, CLSA sees 42% upside potential

CLSA Asia-Pacific Markets gave a Buy rating for Zomato with a target price of Rs 70.

Hindalco tops optimism as China reopens, financials remain Street's top sectoral pick

BUSINESS

Hindalco tops optimism as China reopens, financials remain Street's top sectoral pick

Out of the 10 stocks that analysts were most optimistic about, 5 came from the financial space.

Mold-Tek Packaging shares decline on disappointing Q3 earnings

BUSINESS

Mold-Tek Packaging shares decline on disappointing Q3 earnings

EBIDTA margin contracted by 136 basis points year-on-year to 18.4 percent in the December quarter

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347